We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+4.36%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$401M
AUM Growth
-$49.1M
Cap. Flow
-$51.9M
Cap. Flow %
-12.95%
Top 10 Hldgs %
77.61%
Holding
82
New
5
Increased
1
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
IMMX icon
Immix Biopharma
IMMX
+$3.29M
2
CUE icon
Cue Biopharma
CUE
+$2.35M
3
MODD icon
Modular Medical
MODD
+$1.25M
4
IPWR icon
Ideal Power
IPWR
+$1.2M
5
TALK
Talkspace
TALK
+$680K

Top Sells

Rank Stock Value
1
BC icon
Brunswick
BC
+$48.4M
2
LIN icon
Linde
LIN
+$11M
3
BLUE
bluebird bio
BLUE
+$1.87M
4
SLGCW
SomaLogic, Inc. Warrant
SLGCW
+$1.68K
5
FAZEW
FaZe Holdings Inc. Warrant
FAZEW
+$323

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.85%
2 Healthcare 21.24%
3 Industrials 16.95%
4 Materials 10.55%
5 Consumer Discretionary 10.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$149B
$97.7M 24.38%
475,000
– –
LIN icon
2
Linde
LIN
$226B
$42.3M 10.55%
91,064
-25,500
-22% -$11M
BC icon
3
Brunswick
BC
$4.97B
$41M 10.23%
425,000
-550,636
-56% -$48.4M
INVE icon
4
Identive
INVE
$66.9M
$22.8M 5.7%
2,884,495
– –
FNA
5
DELISTED
Paragon 28, Inc.
FNA
$21.8M 5.43%
1,763,339
– –
GPGI
6
GPGI Inc
GPGI
$3.84B
$21.7M 5.41%
3,609,050
– –
IVAC
7
DELISTED
Intevac Inc
IVAC
$19.3M 4.83%
5,039,023
– –
SPGI icon
8
S&P Global
SPGI
$131B
$17M 4.25%
40,000
– –
MRNS
9
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$16.9M 4.22%
1,872,463
– –
BX icon
10
Blackstone
BX
$107B
$10.5M 2.62%
80,000
– –
MDXH icon
11
MDxHealth
MDXH
$68.8M
$10M 2.51%
3,878,333
– –
INSM icon
12
Insmed
INSM
$25.9B
$8.82M 2.2%
325,000
– –
IDN icon
13
Intellicheck
IDN
$57.6M
$7.22M 1.8%
2,073,583
– –
JPM icon
14
JPMorgan Chase
JPM
$951B
$6.01M 1.5%
30,000
– –
OPTN
15
DELISTED
OptiNose
OPTN
$5.91M 1.47%
269,675
– –
AXP icon
16
American Express
AXP
$225B
$5.69M 1.42%
25,000
– –
DUOT icon
17
Duos Technologies
DUOT
$294M
$5.57M 1.39%
1,283,162
– –
CUE icon
18
Cue Biopharma
CUE
$203M
$5.21M 1.3%
91,834
+33,333
+57% +$2.35M
PROK icon
19
ProKidney
PROK
$382M
$3.28M 0.82%
2,000,000
– –
TV icon
20
Televisa
TV
$1.45B
$3.2M 0.8%
1,000,000
– –
IMMX icon
21
Immix Biopharma
IMMX
$992M
$2.61M 0.65%
+850,000
New +$3.29M
MIST icon
22
Milestone Pharmaceuticals
MIST
$144M
$2.37M 0.59%
1,326,085
– –
LIQT icon
23
LiqTech
LIQT
$18.8M
$1.72M 0.43%
557,110
– –
LSXMK
24
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$1.64M 0.41%
55,216
– –
BRFH icon
25
Barfresh Food Group
BRFH
$20.4M
$1.38M 0.35%
1,153,915
– –
1
2 3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return

Bleichroeder LP's Q1 2024 Portfolio in Review

As of Q1 2024, Bleichroeder LP held 82 positions worth $401M, down 11% from $450M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bleichroeder LP withdrew a net $51.9M in Q1 2024, closing 2 positions and reducing 3 holdings. Its most notable exit was SomaLogic, Inc. Warrant, an estimated $1.68K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Bleichroeder LP opened a new position in Immix Biopharma worth $2.61M.

  • Bleichroeder LP's largest Q1 2024 buy was Immix Biopharma: 850,000 shares worth $2.61M.
  • Bleichroeder LP added most to Cue Biopharma in Q1 2024, an estimated $2.35M increase.
  • Bleichroeder LP's biggest Q1 2024 reduction was Brunswick, cutting an estimated $48.4M.
  • Bleichroeder LP fully exited SomaLogic, Inc. Warrant in Q1 2024, selling an estimated $1.68K.
  • Bleichroeder LP's ten largest holdings make up 78% of its $401M portfolio in Q1 2024.
  • Bleichroeder LP opened 5 new positions and closed 2 in Q1 2024.
  • Bleichroeder LP's portfolio value fell 11% quarter-over-quarter to $401M.

Based on Bleichroeder LP's 13F filing for Q1 2024, filed 14 May 2024.